Partnership
We are always on the look out to build strong partnerships with leading key opinion leaders in the field of auto-immunity to collaborate on new innovative therapies
Strategic Alliances at argenx
Ghent, Belgium
Biotech / Medtech / Start-up
Gent, Belgiumargenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx is translating immunology breakthroughs into a world-class portfolio of novel antibody-based medicines.
HEALTH SECTOR
RESEARCH AND DEVELOPMENT
CLINICAL DEVELOPMENT AND TRIALS
DATA MANAGEMENT AND ANALYTICS
INVESTMENT AND BUSINESS DEVELOPMENT
PATIENT ENGAGEMENT AND ADVOCACY
DIGITAL HEALTH AND TECHNOLOGY
THERAPEUTIC AREAS
Principle Scientist Discovery
argenx
Strategic Alliances
argenx
Scientist Discovery
argenx
Partnership
We are always on the look out to build strong partnerships with leading key opinion leaders in the field of auto-immunity to collaborate on new innovative therapies
Strategic Alliances at argenx
Ghent, Belgium
Expertise
Using our proprietary SIMPLE Antibody™ and Fc engineering platforms, argenx scientists design and optimize antibodies that engage and modulate the immune system, unlocking new therapeutic pathways in autoimmune and rare diseases.
Strategic Alliances at argenx
Ghent, Belgium